DarioHealth Corp.

DRIO - CIK 0001533998

Market cap-

Rank-

SEC filings886

DRIO income statement (quarterly)

The table below shows DarioHealth Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	$5.58M	$5.01M	$5.37M	$6.75M	$7.42M	$6.25M
Cost of revenue	$2.38M	$1.99M	$2.40M	$2.87M	$3.55M	$3.50M
Gross profit	$3.20M	$3.02M	$2.96M	$3.88M	$3.88M	$2.76M
R&D	$2.38M	$3.33M	$3.72M	$4.11M	$5.45M	$6.81M

DRIO annual revenue (10-K history)

DarioHealth Corp. reported annual revenue of $22.36M for fiscal year 2025. That is down 17.3% from $27.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.80M (FY 2016) to $22.36M. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.